160 filings
Page 7 of 8
6-K
xqvrqqlixy6fqen8
17 Jun 21
Immunoprecise Antibodies LTD. 6-K
8:28am
6-K
yj53ylo 2f68rw
15 Jun 21
Immunoprecise Antibodies LTD. 6-K
8:28am
6-K
1evlheap
2 Jun 21
Immunoprecise Antibodies LTD. Form 6-K
9:39pm
S-8
jbhj35r76hnolape1fq7
2 Jun 21
Registration of securities for employees
5:26pm
6-K
q4i1cw3j sm0k8t8lz
25 May 21
Immunoprecise Antibodies LTD. 6-K
8:28am
6-K
cbediuyn06i dvju48u
20 May 21
Immunoprecise Antibodies LTD. 6-K
7:28am
6-K
i840dn cu4qv4rg
21 Apr 21
Immunoprecise Antibodies LTD. 6-K
8:28am
6-K
j3czss b5d4dmag
8 Apr 21
Immunoprecise Antibodies LTD. 6-K
8:08am
6-K
1xfm6wk5f5 rjys0flfu
25 Mar 21
Immunoprecise Antibodies LTD. 6-K
9:03am
6-K
909pm0bxu8k978h40 x4
18 Mar 21
Current report (foreign)
6:05am
6-K
04q683
18 Mar 21
Immunoprecise Antibodies LTD. Form 6-K
12:00am
6-K
31woue5v esdzw051m4j
16 Mar 21
Immunoprecise Antibodies LTD. 6-K
7:57am
6-K
0r7 u0t42kooey108
4 Mar 21
Immunoprecise Antibodies LTD. 6-K
9:02am
6-K
ebmvwn
19 Feb 21
Immunoprecise Antibodies LTD. 6-K
7:30am
6-K
0zm9hy cf
11 Feb 21
IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares
12:00am
6-K
e7etz9sohf1lsksc9a
8 Feb 21
IPA Announces Closing of $21.7 Million Bought Deal Offering of Common Shares
4:35pm
6-K
e01ebum8183ocs c2w
4 Feb 21
Amended and Restated Underwriting Agreement
5:12pm
SUPPL
s39hh7r82rtnh7
4 Feb 21
Supplemental materials (foreign)
5:08pm
FWP
fsmd9
4 Feb 21
Free writing prospectus
12:00am
FWP
rlvenhb
3 Feb 21
Free writing prospectus
9:59pm